Literature DB >> 7271033

Pharmacokinetics of fenbendazole in sheep.

S E Marriner, J A Bogan.   

Abstract

Concentrations of fenbendazole and its sulfoxide, oxfendazole, and sulfone metabolites were determined in 6 sheep after oral administration of fenbendazole (10 mg/kd of body weight). Mean peak concentrations in plasma of fenbendazole, oxfendazole, and sulfone of 0.15, 0.29, and 0.17 micrograms/ml occurred 24, 30, and 36 hours after administration, respectively. Mean peak concentrations in abomasal fluid were 1.82, 0.66, and 0.07 micrograms/ml occurring at 30, 48, and 72 hours, respectively. Fenbendazole and oxfendhzole were detectable in plasma and abomasal fluids for 5 days after administration. Much of the anthelmintic activity of fenbendazole may be due to the oxfendazole metabolite. Plasma concentrations of fenbendazole were less and persisted for a shorter period after intra-abomasal administration than after oral administration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271033

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  The pharmacokinetics of fenbendazole and oxfendazole in cattle.

Authors:  A J Ngomuo; S E Marriner; J A Bogan
Journal:  Vet Res Commun       Date:  1984-08       Impact factor: 2.459

2.  Pharmacokinetics and metabolism of fenbendazole in channel catfish.

Authors:  J V Kitzman; J H Holley; W G Huber; G D Koritz; L E Davis; C A Neff-Davis; R F Bevill; C R Short; S A Barker; L C Hsieh
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

3.  Comparative pharmacokinetics of fenbendazole in buffalo and cattle.

Authors:  M R Knox; P M Kennedy; D R Hennessy; J W Steel; L F Le Jambre
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

4.  Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Authors:  Laura Ceballos; Laura Moreno; Juan J Torrado; Carlos Lanusse; Luis Alvarez
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

5.  Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information.

Authors:  Teppei Yamaguchi; Junichi Shimizu; Yuko Oya; Yoshitsugu Horio; Toyoaki Hida
Journal:  Case Rep Oncol       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.